We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Dentsply (XRAY) Reports Q3 Earnings: What Key Metrics Have to Say
Read MoreHide Full Article
Dentsply International (XRAY - Free Report) reported $951 million in revenue for the quarter ended September 2024, representing a year-over-year increase of 0.4%. EPS of $0.50 for the same period compares to $0.49 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $942.6 million, representing a surprise of +0.89%. The company delivered an EPS surprise of +4.17%, with the consensus EPS estimate being $0.48.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Dentsply performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Organic sales growth: 1.3% compared to the 0.9% average estimate based on six analysts.
Revenues- United States: $374 million versus $354.69 million estimated by three analysts on average.
Revenues- Rest of World: $230 million versus the three-analyst average estimate of $226.53 million. The reported number represents a year-over-year change of -3%.
Revenues- Europe: $347 million versus the three-analyst average estimate of $358.89 million. The reported number represents a year-over-year change of -2%.
Net sales- Connected Technology Solutions: $269 million compared to the $254.26 million average estimate based on five analysts.
Net sales- Wellspect Healthcare: $72 million versus the five-analyst average estimate of $75.87 million.
Net sales- Essential Dental Solutions: $369 million compared to the $345.49 million average estimate based on five analysts.
Net sales- Orthodontic and Implant Solutions: $241 million versus $261.83 million estimated by five analysts on average.
Adjusted Operating Income- Connected Technology Solutions: $16 million versus $17.68 million estimated by two analysts on average.
Adjusted Operating Income- Wellspect Healthcare: $26 million versus the two-analyst average estimate of $22.19 million.
Adjusted Operating Income- Orthodontic and Implant Solutions: $24 million versus the two-analyst average estimate of $40.81 million.
Adjusted Operating Income- Essential Dental Solutions: $132 million versus the two-analyst average estimate of $113.81 million.
Shares of Dentsply have returned -2.2% over the past month versus the Zacks S&P 500 composite's +3.2% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Dentsply (XRAY) Reports Q3 Earnings: What Key Metrics Have to Say
Dentsply International (XRAY - Free Report) reported $951 million in revenue for the quarter ended September 2024, representing a year-over-year increase of 0.4%. EPS of $0.50 for the same period compares to $0.49 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $942.6 million, representing a surprise of +0.89%. The company delivered an EPS surprise of +4.17%, with the consensus EPS estimate being $0.48.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Dentsply performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Organic sales growth: 1.3% compared to the 0.9% average estimate based on six analysts.
- Revenues- United States: $374 million versus $354.69 million estimated by three analysts on average.
- Revenues- Rest of World: $230 million versus the three-analyst average estimate of $226.53 million. The reported number represents a year-over-year change of -3%.
- Revenues- Europe: $347 million versus the three-analyst average estimate of $358.89 million. The reported number represents a year-over-year change of -2%.
- Net sales- Connected Technology Solutions: $269 million compared to the $254.26 million average estimate based on five analysts.
- Net sales- Wellspect Healthcare: $72 million versus the five-analyst average estimate of $75.87 million.
- Net sales- Essential Dental Solutions: $369 million compared to the $345.49 million average estimate based on five analysts.
- Net sales- Orthodontic and Implant Solutions: $241 million versus $261.83 million estimated by five analysts on average.
- Adjusted Operating Income- Connected Technology Solutions: $16 million versus $17.68 million estimated by two analysts on average.
- Adjusted Operating Income- Wellspect Healthcare: $26 million versus the two-analyst average estimate of $22.19 million.
- Adjusted Operating Income- Orthodontic and Implant Solutions: $24 million versus the two-analyst average estimate of $40.81 million.
- Adjusted Operating Income- Essential Dental Solutions: $132 million versus the two-analyst average estimate of $113.81 million.
View all Key Company Metrics for Dentsply here>>>Shares of Dentsply have returned -2.2% over the past month versus the Zacks S&P 500 composite's +3.2% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.